Compartmentalized metabolism supports midgestation mammalian development

Area of Science:

• Developmental Biology
• Metabolomics
• Biochemistry

Background:

• Mammalian embryogenesis requires precise metabolic control for rapid growth.
• Midgestation involves increased nutrient and oxygen supply supporting fetal organ development.
• Observing in utero metabolism is crucial for understanding developmental support.

Purpose of the Study:

• To identify evolving metabolic programs in the placenta and embryo during mouse midgestation.
• To understand how metabolism supports fetal development in utero.
• To investigate the metabolic consequences of LIPT1 deficiency during embryogenesis.

Main Methods:

• Utilized isotope tracing and metabolomics to analyze metabolic pathways.
• Examined metabolic differences between placenta and embryo tissues.
• Investigated LIPT1-deficient mice to model metabolic defects.

Main Results:

• Identified gestational days (GD) 10.5-11.5 as a key metabolic transition period for both embryo and placenta.
• Revealed distinct carbohydrate metabolism and glucose-dependent purine synthesis in the embryo.
• Observed compartmentalized metabolic programs within embryonic organs by GD12.5.
• Demonstrated that LIPT1 deficiency disrupts tricarboxylic acid (TCA) cycle metabolism, leading to developmental defects and embryonic demise.

Conclusions:

• Placenta and embryo exhibit distinct, evolving metabolic programs during midgestation.
• Glucose is a critical fuel source for purine synthesis and the TCA cycle in the developing embryo.
• Disruption of TCA cycle enzyme activation (LIPT1 deficiency) severely impacts embryonic development and viability.